Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats

Abstract excerpt

Bisphosphonates are clinically used mainly to reduce bone resorption. We studied the transplacental effects of two bisphosphonates on the fetal skeleton in rats. Pregnant rats were treated during days 11-20 of pregnancy with daily subcutaneous injections of 0.1 mg/kg of alendronate or a newly synthesized bisphosphonate, VS-b6. This period of pregnancy was chosen because the active development of bones from...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone health and osteoporosis research
• Share to Bone health and treatments
• Share to Connective tissue disorders research